Clinical Trial Update: 52-104 Week Off-therapy Second Extension to Study CSPP100A2365

View source ↗

Summary

Clinical trial update for CSPP100A2365 reports a 52-104 week off-therapy second extension; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CSPP100A2365

Snippet

Sponsor: Noden Pharma | Conditions: Hypertension | Status: COMPLETED | Results posted: 2019-02-15